Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 Next Page Last Page
 
1
Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17?-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
2011-01-12

Use of oral contraceptives (OC) that combine a progestogen with synthetic ethinyl estradiol (EE) is associated with increased risk of venous thromboembolism. NOMAC/E2 is a new monophasic OC that combines nomegestrol acetate (NOMAC), a highly selective progestogen, with 17?-estradiol (E2). The ...

PubMed

2
Nomegestrol acetate, a novel progestogen for oral contraception.
2011-02-16

Nomegestrol acetate (NOMAC) is a potent, highly selective progestogen, which is structurally similar to 19-norprogesterone and characterized as a full agonist at the progesterone receptor, with no or minimal binding to other steroid receptors, including the androgen and glucocorticoid receptors. In animal models, NOMAC demonstrated ...

PubMed

3
Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17?-estradiol (NOMAC/E2): a double-blind, randomized study.
2011-03-18

BACKGROUND Nomegestrol acetate/17?-estradiol (NOMAC/E(2)) is a new monophasic oral contraceptive combining NOMAC (2.5 mg), a highly selective progesterone-derived progestogen, with E(2) (1.5 mg), which is structurally identical to endogenous estrogen. The objective of this study was to compare the effects on ...

PubMed

4
Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.

Nomegestrol acetate (NOMAC), a 17alpha-hydroxy-nor-progesterone derivative (17alpha-acetoxy-6-methyl-19-nor-4,6-pregnadiene-3,20-dione, the active substance in Lutenyl), is a potent and useful clinical synthetic progestin for the treatment of menopausal complaints and is under current development for oral contraception. Previous studies in this laboratory ...

PubMed

5
Ethinyl Estradiol; Norethindrone Acetate

... Contains Nonbinding Recommendations Draft Guidance on Ethinyl Estradiol and Norethindrone Acetate ... Active ingredient: Ethinyl Estradiol; Norethindrone Acetate ...

Center for Biologics Evaluation and Research (CBER)

6
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17?-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function.
2011-09-26

ABSTRACT Objectives To compare the effects of two monophasic combined oral contraceptives, containing either nomegestrol acetate/17?-oestradiol (NOMAC/E2) or levonorgestrel/ ethinylestradiol (LNG/EE) on endocrine function, androgens, and sex hormone-binding globulin (SHBG). Methods Randomised, open-label, multi-centre trial involving 121 healthy women, ...

PubMed

7
Metabolic effects of contraceptive steroids.
2011-06-01

Estrogen and progestins have been used by millions of women as effective combined contraceptives. The safety of hormonal contraceptives has been documented by years of follow-up and serious adverse events that may be related to their use are rare in the young population exposed to these agents. The balance between the benefits and the risks of contraceptive steroids is generally positive in ...

PubMed

8
[Nomegestrol acetate: clinical pharmacology].
2009-10-01

Progestogens are used in clinical practice in some conditions. Their effects depend on their chemical structure, pharmacokinetics, pharmacodynamics, with important differences among various progestogens. Generally, progestins are classified according to their parent molecule, of which often they keep some features. Derivatives of 19-nor-progesterone are characterized by high selectivity of action ...

PubMed

9
Draft Guidance on Estradiol; Norethindrone Acetate Active ...

... Analytes to measure (in appropriate biological fluid): Estradiol (unconjugated), estrone (total), estrone (unconjugated), and norethindrone in plasma. ...

Center for Biologics Evaluation and Research (CBER)

10
21 CFR 522.2478 - Trenbolone acetate and estradiol benzoate.
2011-04-01

...2011-04-01 false Trenbolone acetate and estradiol benzoate. 522.2478 Section 522...522.2478 Trenbolone acetate and estradiol benzoate. (a) Specifications ...mg) trenbolone acetate and 3.5 mg estradiol benzoate. (2) 4 pellets,...

Code of Federal Regulations, 2011

11
21 CFR 522.2478 - Trenbolone acetate and estradiol benzoate.
2010-04-01

...2010-04-01 false Trenbolone acetate and estradiol benzoate. 522.2478...ANIMAL DRUGS § 522.2478 Trenbolone acetate and estradiol benzoate. (a) Specifications...containing 25 milligrams (mg) trenbolone acetate and 3.5 mg estradiol benzoate....

Code of Federal Regulations, 2010

12
21 CFR 522.2477 - Trenbolone acetate and estradiol.
2011-04-01

...estradiol, and 1 pellet containing 29 mg tylosin tartrate) per implant dose. (C...estradiol, and 1 pellet containing 29 mg tylosin tartrate) per implant dose. (F...estradiol, and 1 pellet containing 29 mg tylosin tartrate) per implant dose....

Code of Federal Regulations, 2011

13
Androgens Inhibit Estradiol-17? Synthesis in Atlantic Croaker (Micropogonias undulatus) Ovaries by a Nongenomic ...

... which was not reversed by cotreatment with the antiandrogens, cyproterone acetate or 1,1-dichloro-2,2- ... as described previously [20]. Effect of Androgens and Antiandrogens on In Vitro Estradiol Produc...

NBII National Biological Information Infrastructure

14
Radioimmunological Determination of Plasma Androstenedione and Dehydroepiandrosterone Levels in Hirsute Women Before and During Therapy Using Cyproterone Acetate and Ethinyl Estradiol.
1982-01-01

Plasma androstenedione and dehydroepiandrosterone levels were determined in 54 hirsute women before and after treatment with cyproterone acetate and ethinyl estradiol. Anderostenione levels were, on an average, significantly higher than in normal control ...

National Technical Information Service (NTIS)

15
HT update: spotlight on estradiol/norethindrone acetate combination therapy
2008-03-01

The goal of postmenopausal hormone therapy is to alleviate the symptoms that are associated with the loss of estrogen. Many formulations of estrogen and progestin are available, depending on the needs and circumstances of each individual woman. For postmenopausal women, the choice of whether or not to begin therapy requires knowledge of the risks and benefits of estrogen and/or progestin ...

PubMed Central

16
Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators
2011-04-19

Selective estrogen receptor modulators, such as estradiol 17?-derived metal complexes, have been synthesized as targeted probes for the diagnosis and treatment of breast cancer. Here, we report the detailed 3D structure of estrogen receptor alpha ligand-binding domain (ER?-LBD) bound with a novel estradiol-derived metal complex, ...

PubMed Central

17
Variation of lead-induced lethality in estradiol-treated mice
1982-03-01

Studies were undertaken to test the female sex hormone ..beta..-estradiol for its ability to modify lethality in young adult female and male mice exposed to lead acetate. Mice were injected with ..beta..-estradiol on day -1 and 0, and immediately after the second injection lead acetate was administered at four ...

Energy Citations Database

18
Rapid Androgen Actions on Calcium Signaling in Rat Sertoli Cells and Two Human Prostatic Cell Lines: Similar Biphasic ...

... calcium signaling. Similarly, progesterone and estradiol-17β; two antiandrogens, cyproterone acetate (CPA) and HF; and the inhibitor ... clear differences, especially with respect to effects of antiandrog...

NBII National Biological Information Infrastructure

19
NCI Thesaurus

Exact Match  Begins With  Contains Name/Code  Property  Relationship Home | View Hierarchy | Subsets | Help Visited Concepts EVS Home NCI Metathesaurus Browser NCI Term Browser NCI Terminology Resources Term Suggestion Estradiol Acetate (Code C47990) Suggest

Cancer.gov

20
Estradiol-17β Is Produced in Bovine Corpus Luteum1

... 3.5 with acetic acid and extracted using diethyl ether as described previously [25]. The residue was dissolved ... early CL were extracted with 12 ml of diethyl ether (pH 3.5). After evaporation, they wer...

NBII National Biological Information Infrastructure

First Page Previous Page 1 2 Next Page Last Page
 
First Page Previous Page 1 2 Next Page Last Page
 
21
Bleeding patterns during continuous combined estrogen-progestogen therapy.
1991-05-01

Bleeding and climacteric symptoms were recorded in two groups of postmenopausal women receiving either continuous combined estradiol and norethisterone acetate or estradiol and cyproterone acetate. Out of a sample of 99 postmenopausal women aged 45 to 54 years, 86 completed a 2-year, double-blind, ...

PubMed

22
Nsc-112 259 (Estradiol Mustard) Preclinical Toxicological Evaluation of Oral Treatment in Monkeys (Q. 4 Day, 11 Treatments).
1970-01-01

Estradiol mustard (NSC-112 259) Estra-1,3,5,(10)-triene-3, 17B-diol, bis ((para-(bis(2-chloroethyl)amino)phenyl)acetate), a compound with antitumor activity, was submitted to a preclinical toxicological evaluation in 10 Rhesus monkeys. The animals survive...

National Technical Information Service (NTIS)

23
Simultaneous determination of estradiol valerate and medroxyprogesterone acetate in a tablet formulation by gas chromatography-mass spectrometry.
2010-01-01

A new and simple gas chromatography-mass spectrometry (GC-MS) method has been developed for simultaneous determination of estradiol valerate (EV) and medroxyprogesterone acetate (MPA) in a tablet formulation. The validation of the proposed method was carried out for selectivity, linearity, accuracy, precision, recovery, limits of detection and ...

PubMed

24
Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 ?g ethinyl estradiol and 2 mg cyproterone acetate.
2011-04-18

Objectives.?To investigate the influence of 6 months of treatment with an oral contraceptive (OC) containing 35??g ethinyl estradiol and 2 mg cyproterone acetate on plasma viscosity (PV) in young women with polycystic ovary syndrome (PCOS). Design.?Patients with PCOS were assessed for PV before and after 6 months of treatment with an OC containing 35??g ...

PubMed

25
Structure of estradiol metal chelate and estrogen receptor complex: the basis for designing a new class of selective estrogen receptor modulators.
2011-04-19

Selective estrogen receptor modulators, such as 17?-estradiol derivatives bound to metal complexes, have been synthesized as targeted probes for the diagnosis and treatment of breast cancer. Here, we report the detailed 3D structure of estrogen receptor ? ligand-binding domain (ER?-LBD) bound with a novel estradiol-derived metal complex, ...

PubMed

26
Design of an intravaginal ring for the controlled delivery of 17 beta-estradiol as its 3-acetate ester.
1999-09-20

Suitable ester prodrugs of 17beta-estradiol are identified, thus permitting effective sustained and controlled estrogen replacement therapy (ERT) from an elastomeric, silicone intravaginal ring (IVR). IVR devices of reservoir design were prepared by blending silicone elastomer base with n-propylorthosilicate (cross-linker) and 10% w/w of 17beta-estradiol ...

PubMed

27
Inhibition of Aberrant Androgen Receptor Induction of Prostate Specific Antigen Gene Expression, Cell Proliferation and Tumor Growth by 17?-Estradiol in Prostate Cancer
2011-01-01

PurposeAndrogen independent prostate cancer growth and metastasis are a major cause of prostate cancer death. Aberrant androgen receptor activation due to androgen receptor mutation is an important mechanism of androgen independence. We determined the effectiveness and mechanism of 17?-estradiol (Sigma�) in blocking aberrant androgen receptor activation due to androgen ...

PubMed Central

28
Effects of long-term treatment with 17 beta-estradiol and medroxyprogesterone acetate on water maze performance in middle aged female rats.
2010-04-01

Although previous research has indicated that hormone replacement therapy benefits memory in menopausal women, several recent studies have shown either detrimental or no effects of treatment. These inconsistencies emphasize the need to evaluate the role of ovarian hormones in protecting against age-related cognitive decline in an animal model. The present study investigated the effects of ...

PubMed

29
Effects of long term treatment with 17 ?-estradiol and medroxyprogesterone acetate on water maze performance in middle aged female rats
2010-04-01

Although previous research has indicated that hormone replacement therapy benefits memory in menopausal women, several recent studies have shown either detrimental or no effects of treatment. These inconsistencies emphasize the need to evaluate the role of ovarian hormones in protecting against age-related cognitive decline in an animal model. The present study investigated the effects of long ...

PubMed Central

30
Synchronization of follicular wave emergence in the seasonally anestrous ewe: the effects of estradiol with or without medroxyprogesterone acetate.
2008-02-06

Fertility is often lower in anestrous compared to cyclic ewes, after conventional estrus synchronization. We hypothesized that synchronization of ovarian follicular waves and ovulation could improve fertility at controlled breeding in anestrous ewes. Estradiol-17beta synchronizes follicular waves in cattle. The objectives of the present experiments were to study the effect of ...

PubMed

31
current as of August 22, 2008. Online article and related content

medroxyprogesterone acetate (MPA) increased the risk for probable dementia in postmenopausal women aged 65 years and 19-norprogesterone and antagonism by me- droxyprogesterone acetate. Endocrinology. 2002;143:205-212. 3. Nilsen J, Brinton RD. Impact of progestins on estradiol-potentiation of the glu- tamate calcium

E-print Network

32
Synthesis of C-2 and C-4 deuterium-labeled estradiol-17 beta
1983-06-01

Estradiol-17 beta labeled with deuterium in the positions 2 or 4 can be prepared from 2-chloromercurio-1,3,5(10)-estratriene-3,17 beta-diol 3-methyl ether 17-acetate or 4-chloromercurio-1,3,5(10)-estratriene-3,17 beta-diol, respectively, in refluxing CH3COO(2)H/(2)H2O. The same reaction performed on 4-acetoxymercurio-1,3,5(10)-estratriene-3,17 beta-diol ...

Energy Citations Database

33
Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years
1978-01-01

After four years of a long term contraceptive steroid safety study, the incidence and the histologic type of mammary dysplasia produced is similar in beagles treated with medroxyprogesterone acetate (medroxyprogesterone) or progesterone. Serum insulin, thyroid stimulating hormone (TSH), triiodothyronine, growth hormone, prolactin, 17..beta..-estradiol, ...

Energy Citations Database

34
JAMMING TESTS ON NOMAC SYSTEMS
1953-09-25

... USN HAE00UA! I IN H ii Fig. .. 2. Liea ..... ed .reec Iy e using. phase.m..u..ti. n 1,41 MIq 1A' REFRSECRET F!%ENC Page 20. SECRET ..... ...

DTIC Science & Technology

35
Effect of axial power distribution on vehicle thrust: hand estimate. PTN- A No. 287
1963-11-19

LRL has been performed. The figures presented are representaive, but must be expected to change slightly as design work continues. Machine calculations were performed with FLOSS III and its companion programs, NOMAC and DASH N. (auth)

Energy Citations Database

36
Blood Test: Estradiol

What It Is An estradiol test measures the level of the hormone estradiol in the bloodstream. Estradiol plays an important role in sexual development: It's ...

MedlinePLUS

37
Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
2011-09-19

OBJECTIVE:: The aim of the study was to compare the responses of heart rate variability (HRV) with hormone therapy in recently postmenopausal women with and without vasomotor hot flashes. METHODS:: Seventy-two women with and 78 women without hot flashes were randomized to receive transdermal estradiol gel (1 g/day), oral estradiol alone (2 mg/day), oral ...

PubMed

38
Human placental estradiol 17. beta. -dehydrogenase: evidence for inverted substrate orientation (wrong-way binding) at the active site
1988-06-14

Human placental estradiol 17..beta..-dehydrogenase was affinity labeled with 17lambda-estradiol 17-(bromo(2-/sup 14/C)acetate) (10 ..mu..M) or 17..beta..-estradiol 17-(bromo(2-/sup 14/C)acetate) (10 ..mu..M). The steroid bromoacetates competitively inhibit the enzyme (against ...

Energy Citations Database

39
Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
2008-12-25

Estrogen stimulates proliferation in hormone-responsive breast cancer cells. Progestins inhibit the estrogen-mediated growth in these cells and are used in the treatment of mammary carcinomas. We applied cDNA microarray and real-time RT-PCR methods to reveal 17beta-estradiol- and medroxyprogesterone acetate (MPA)-regulated genes in MCF-7 breast cancer ...

PubMed

First Page Previous Page 1 2 Next Page Last Page